Company Search:
Advanced Search
Sponsored Links
Kancera AB Company Snapshot
Kancera AB operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kancera AB with three other pharmaceutical manufacturers in Europe: Bionor Pharma ASA of Norway (2015 sales of 85,000.00 Norwegian Kroner [US$10,425.25 ] of which 100% was Others), Futura Medical PLC of the United Kingdom (£29,476.00 [US$36,255.77 ] of which 100% was Pharmaceuticals), and OptiBiotix Health PLC which is also based in the United Kingdom (£28,200.00 [US$34,686.28 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kancera AB
  Stock Performance Chart for Kancera AB
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 3.20
(Figures in Swedish Kronor)
1 Week -5.0%   13 Weeks -1.5%  
4 Weeks 26.0%   52 Weeks -30.3%  
Kancera AB Key Data:
  Ticker: KAN Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 282,000
(Year Ending Jan 2016).
Employees: 13
  Currency: Swedish Kronor Market Cap: 420,757,504
  Fiscal Yr Ends: December Shares Outstanding: 131,486,720
  Share Type: AKTIER Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.